Leiomyosarcoma (LMS) Completed Phase 2 Trials for Dexrazoxane (DB00380)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

Indication	Status	Phase
DBCOND0118909 (Leiomyosarcoma (LMS))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02584309	Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma	Treatment	Dexrazoxane (DB00380) Doxorubicin (DB00997)